Showing 931-940 of 6907 results for "".
Using Transepidermal Water Loss to Guide Oral Food Challenges
https://reachmd.com/programs/Audioabstracts/transepidermal-water-loss-guide-oral-food-challenges/54217/Can real-time transepidermal water loss (TEWL) monitoring reduce the risk of anaphylaxis during oral food challenges in young children with peanut allergy? A pilot trial suggests it may. TEWL-guided stopping significantly lowered anaphylaxis rates and reaction severity without delaying treatment. ThDARE AF Trial: Dapagliflozin to Reduce AF Burden After Catheter Ablation in Patients Without Diabetes or Heart Failure
https://reachmd.com/clinical-practice/cardiology/dare-af-trial-dapagliflozin-to-reduce-af-burden-after-catheter-ablation-in-patients-without-diabetes-or-heart-failure/48682/Can dapagliflozin reduce AF burden in your patients without diabetes or heart failure after ablation? Our expert is breaking down the DARE-AF trial results!Escalate With Intention: Stepwise, Target-Anchored Moves
https://reachmd.com/programs/cme/escalate-with-intention-stepwise-target-anchored-moves/54773/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
https://reachmd.com/programs/medical-industry-feature/anti-amyloid-therapy-early-alzheimers-real-world/48941/Explore the clinical use of the anti-amyloid therapy LEQEMBI® (lecanemab-irmb) for early Alzheimer’s disease in this four-part, on-demand video series. The program offers expert-led guidance on patient selection and monitoring, 4-year efficacy and safety data, and emerging real-world evidence. FeatuHighlights from VBS 2026: From Care Innovations to Clinician Wellness
https://reachmd.com/programs/eye-on-ocular-health/vbs-2026-innovations-clinician-wellness/56547/The 2026 Vit-Buckle Society (VBS) Annual Meeting featured candid case-based discussions on real-world complications and innovative approaches, as well as sessions dedicated to promoting physician wellness. Catch up on insights from this year's meeting with Dr. Akshay Thomas, a vitreoretinal surgeonUnraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
https://reachmd.com/programs/neurofrontiers/unraveling-the-mechanism-how-ocrelizumab-impacts-cortical-lesions-in-ms/32367/While B-cell follicles in the brain’s meninges were previously suspected to drive cortical lesions in multiple sclerosis (MS), studies show ocrelizumab has little impact on B-cell follicles—yet it still significantly reduces cortical lesions. This suggests that another, yet-to-be-understood B-cell-mDWTV Extra: New Tapinarof Data for AD
https://reachmd.com/series/dermwire-tv/dwtv-extra-new-tapinarof-data-for-ad/33940/Linda Stein Gold, MD, discusses the results from the Phase 3 ADORING 3 open-label, long-term extension study evaluating tapinarof cream, 1% once daily in children as young as 2 and adults with atopic dermatitis, presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in OrlandoHighlights from the 2023 Psych Congress
https://reachmd.com/programs/neurofrontiers/a-preview-of-the-2023-psych-congress/15899/Join in for a listen into what’s to come at this year’s 2023 Psych Congress.Spotlight on Cardiac Imaging
https://reachmd.com/programs/heart-matters/spotlight-on-cardiac-imaging/14177/At this year's ESC 2022 Congress, clinicians are highlighting developments in cardiac imaging. What do we need to know about the latest advancements in cardiac imaging, and how may these advancements alter the field of cardiovascular diagnostics?Looking to the Future of Gastroenterology: Where Are We Headed?
https://reachmd.com/programs/gi-insights/looking-to-the-future-of-gastroenterology-where-are-we-headed/13851/What might the practice of gastroenterology look like 10 years from now? Join us as we work to clear up that crystal ball.